• Home
  • News
  • Sport
  • Politics
  • Column
  • Business
  • Life & Style
    • Crime
    • R&D Health
    • Diet and Fitness
    • Intimacy
  • Entertainment
    • Photos
    • Fashion
    • Movies
    • Music
  • Videos
Facebook Twitter Instagram
Trending
  • Kogi 2023: First Lady receives Governor-elect, Ododo, Bello
  • Napoli name Osimhen asking price amid Chelsea links
  • Substance Abuse: Think Tank On Nigeria speaks on how to curb menace 
  • Northern Senators ask Niger military junta to release ousted President Bazoum
  • Appeal court sacks Nasarawa Speaker
  • FG woos foreign mining investors with lower production cost
  • Tinubu tasks NSE on Renewed Hope Agenda
  • Mother of Kano wanted thug hands son over to police
Facebook Twitter Instagram
The Eagle OnlineThe Eagle Online
  • Home
  • News
  • Sport
  • Politics
  • Column
  • Business
  • Life & Style
    • Crime
    • R&D Health
    • Diet and Fitness
    • Intimacy
  • Entertainment
    • Photos
    • Fashion
    • Movies
    • Music
  • Videos
The Eagle OnlineThe Eagle Online
Home»R&D Health»Congo to introduce second vaccine against Ebola in mid-October
R&D Health

Congo to introduce second vaccine against Ebola in mid-October

The Eagle OnlineBy The Eagle OnlineSeptember 23, 2019Updated:September 23, 2019No Comments
Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email

Congo will introduce a second vaccine against Ebola from mid-October, the World Health Organisation said on Monday, as the central African country continues to battle what has become the second-worst outbreak of the disease in history.
“The DRC authorities … have once again shown leadership and their determination to end this outbreak as soon as possible,” WHO Director-General Tedros Adhanom Ghebreyesus said in a statement.
The hemorrhagic fever has infected more than 3,000 people and killed at least 2,000 since an outbreak was declared 13 months ago in Congo’s volatile eastern region.
The WHO declared it an international health emergency in July, after the disease spread to Goma, a major urban centre near the border with Rwanda.
The second vaccine, manufactured by Johnson & Johnson, will be given to “at-risk populations in areas that do not have active Ebola transmission as an additional tool to extend protection against the virus,” the WHO said.
Congolese authorities have said they want to target small-scale Congolese traders who cross into Rwanda.
The current vaccine, produced by Merck, has been given to more than 223,000 people at high risk of Ebola, including those who had contact with an infected person.
Congo’s former health minister, Oly Ilunga, had in July criticised what he said was pressure to use a new Ebola vaccine to try to stem the spread of the virus.
He is now under investigation for allegedly embezzling Ebola funds.
Curbing the spread of the virus in eastern Congo has proved difficult because of the numerous rebel groups operating in the area and a local population suspicious of health workers.
dpa/NAN.

DRC Ebola WHO
Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
The Eagle Online

Related Posts

Substance Abuse: Think Tank On Nigeria speaks on how to curb menace 

November 28, 2023

Tinubu scheduled for UAE to attend COP28 Climate Summit

November 28, 2023

MNCH: USAID BA-N commits to promoting greater access

November 28, 2023
© 2023 All Rights Reserved. The Eagle Online.
  • Home
  • Privacy Policy
  • Advert Rates
  • Submit News
  • Contact Us

Type above and press Enter to search. Press Esc to cancel.